These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model. Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357 [TBL] [Abstract][Full Text] [Related]
5. Combinations of nonlabeled, 125I-labeled, and anti-idiotypic antiplacental alkaline phosphatase monoclonal antibodies at experimental radioimmunotargeting. Rossi Norrlund R; Holback D; Johansson L; Hietala SO; Ahlström KR Acta Radiol; 1997 Nov; 38(6):1087-93. PubMed ID: 9394676 [TBL] [Abstract][Full Text] [Related]
6. Dosimetric comparison of bolus and continuous injections of CC49 monoclonal antibody in a colon cancer xenograft model. Roberson PL; Dudek S; Buchsbaum DJ Cancer; 1997 Dec; 80(12 Suppl):2567-75. PubMed ID: 9406711 [TBL] [Abstract][Full Text] [Related]
7. Dosimetry of fractionated administration of 125I-labeled antibody at experimental radioimmunotargeting. Ullén A; Sandström P; Rossi Norrlund R; Rathsman S; Johansson L; Riklund Ahlström K; Hietala SO; Stigbrand T Cancer; 1997 Dec; 80(12 Suppl):2510-8. PubMed ID: 9406704 [TBL] [Abstract][Full Text] [Related]
8. Antibody targeted therapy in cancer: comparison of murine and clinical studies. Begent RH; Pedley RB Cancer Treat Rev; 1990 Sep; 17(2-3):373-8. PubMed ID: 2272053 [TBL] [Abstract][Full Text] [Related]
9. Animal models for radiolabeled monoclonal antibodies in cancer research. Aas M; Fjeld JG Acta Oncol; 1993; 32(7-8):819-24. PubMed ID: 8305231 [TBL] [Abstract][Full Text] [Related]